Joel Rosh MD
Professor of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Join to view full profile
1991 Marcus AvenueSuite M100Lake Success, NY 11042
Phone+1 516-472-3650
Fax+1 516-472-3654
Dr. Rosh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Gastroenterology, 1989 - 1990
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1986 - 1989
Albert Einstein College of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1987 - 2027
NJ State Medical License 1993 - 2023
American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Inside Jersey - Top Doctors for Children Castle Connolly, 2010-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
Clinical Trials
- Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
- Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry Start of enrollment: 2002 Jan 28
Publications & Presentations
PubMed
- Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study.Ricardo G Suarez, Ori Bar Or, Esther Orlanski-Meyer, Zivia Shavit, Asaf Azulay
Inflammatory Bowel Diseases. 2026-10-01 - Providing care at a most vulnerable time.Paula Prieto Tizzard, Shervin Rabizadeh, Joel R Rosh
Crohn's & Colitis 360. 2026-04-01 - 3 citationsUstekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.Elisabeth De Greef, Dan Turner, Jarosław Kierkuś, Bartosz Korczowski, Monika Meglicka
Journal of Crohn's & Colitis. 2026-03-10
Journal Articles
- Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn’s & Colitis Foundation: Charting the Future of Pediatric IBDJoel R Rosh, Athos Bousvaros, Laurie S Conklin, David Ziring, K T Park, Subra Kugathasan, Michael D Kappelman, Andrew B Grossman, Jeffrey S Hyams, Lee A Denson, Andrew..., Inflammatory Bowel Diseases
- Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in ChildrenSubra Kugathasan, Robert N Baldassano, Lee A Denson, Joshua D Noe, Jeffrey S Hyams, Cary G Sauer, David J Keljo, Joel R Rosh, Melvin B Heyman, Neal S LeLeiko, Marian D..., Inflammatory Bowel Diseases
- IBD LIVE Case Series: Case 9: Do Race and Extraintestinal Manifestations Affect Treatment of Severe Crohn’s Colitis?David J Keljo, Joel R Rosh, Samir A Shah, Myron H Brand, Brian K Theisen, Hans H Herfarth, Walter A Koltun, Julia B Greer, Corey A Siegel, Raymond K Cross, Peter L Davis, Inflammatory Bowel Diseases
Press Mentions
- Transition to Long-Term IBD Care Relies on Open Communication, Patient MonitoringJanuary 21st, 2022
IBD Pediatric Costs & Cannabis Still No Data for IBDApril 25th, 2020
Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in ChildrenFebruary 24th, 2018
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
